Abstract | PURPOSE: METHODS: RESULTS:
Titanocene dichloride in the dosage of 3 x 30 mg/kg and 3 x 20 mg/kg brought about a significant reduction in tumour volume (p < 0.05) compared to the control group and to the treatment group under medication with titanocene dichloride 1 x 30 mg/kg. There were no significant changes in the body weight of nude mice. CONCLUSION:
|
Authors | C Villena-Heinsen, M Friedrich, A K Ertan, W Schmidt |
Journal | Clinical and experimental obstetrics & gynecology
(Clin Exp Obstet Gynecol)
Vol. 25
Issue 1-2
Pg. 5-8
( 1998)
ISSN: 0390-6663 [Print] Singapore |
PMID | 9743868
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Organometallic Compounds
- titanocene dichloride
|
Topics |
- Animals
- Antineoplastic Agents
(administration & dosage)
- Body Weight
- Cystadenocarcinoma, Serous
(drug therapy)
- Evaluation Studies as Topic
- Female
- Humans
- Mice
- Mice, Nude
- Neoplasm Transplantation
- Organometallic Compounds
(administration & dosage)
- Ovarian Neoplasms
(drug therapy)
|